Loading clinical trials...
Loading clinical trials...
Safety and Efficacy of TVERP in BPH Patients With Prostate Size ˃30 and ≤80 ml: a Comparison Study Between TVERP With the Plasma Vaporisation Button, Bipolar TURis and HoLEP Treatments.
Conditions
Interventions
TVERP
TURis
+1 more
Locations
3
China
Renmin Hospital,Wuhan University
Wuhan, Hubei, China
West China Hospital, Sichuan University
Chengdu, Sichuan, China
The First Affiliated Hospital, College of Medicine, Zhejiang University
Hangzhou, Zhejiang, China
Start Date
August 27, 2020
Primary Completion Date
August 1, 2022
Completion Date
August 1, 2022
Last Updated
January 9, 2023
NCT07377929
NCT05308017
NCT00427219
NCT02401581
NCT02051036
NCT02509975
Lead Sponsor
Olympus Surgical Technologies Europe
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions